Found 7 matching trials
Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase
PHASE3This is a multi-center, open-label, switchover trial to assess the safety o...
Location
University Research Foundation for Lysosomal Storage Diseases, Inc.
Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial
PHASE3Gaucher disease, the most prevalent lysosomal storage disorder, is caused b...
Location
Department of Human Genetics, Emory University School of Medicine
Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)
PHASE1Gaucher disease, the most prevalent lysosomal storage disorder, is caused b...
Location
Multiple Locations
An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
PHASE2The purpose of this study is to evaluate the efficacy and safety of autolog...
Location
Multiple Locations
A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease
PHASE3Gaucher disease, the most prevalent lysosomal storage disorder, is caused b...
Location
University Research Foundation for Lysosomal Storage Diseases
Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
N/AThis is an open-label expanded access trial of prGCD in patients with Gauch...
Status
No Longer Available
Location
La Jolla Village Family Medical Group
Safety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease Patients
PHASE1Absorption of therapeutic proteins taken orally has remained the major hurd...
Location
Rambam Medical Center